Correlation Between Dianthus Therapeutics and Altimmune

Can any of the company-specific risk be diversified away by investing in both Dianthus Therapeutics and Altimmune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dianthus Therapeutics and Altimmune into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dianthus Therapeutics and Altimmune, you can compare the effects of market volatilities on Dianthus Therapeutics and Altimmune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dianthus Therapeutics with a short position of Altimmune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dianthus Therapeutics and Altimmune.

Diversification Opportunities for Dianthus Therapeutics and Altimmune

-0.61

Correlation Coefficient

Dianthus Therapeutics  Altimmune

Excellent diversification

The 3 months correlation between Dianthus and Altimmune is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Dianthus Therapeutics and Altimmune in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Altimmune and Dianthus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dianthus Therapeutics are associated (or correlated) with Altimmune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Altimmune has no effect on the direction of Dianthus Therapeutics i.e., Dianthus Therapeutics and Altimmune go up and down completely randomly.

Pair Corralation between Dianthus Therapeutics and Altimmune

Given the investment horizon of 90 days Dianthus Therapeutics is expected to generate 0.66 times more return on investment than Altimmune. However, Dianthus Therapeutics is 1.52 times less risky than Altimmune. It trades about 0.11 of its potential returns per unit of risk. Altimmune is currently generating about -0.03 per unit of risk. If you would invest  2,234  in Dianthus Therapeutics on September 23, 2024 and sell it today you would earn a total of  146.00  from holding Dianthus Therapeutics or generate 6.54% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Dianthus Therapeutics  vs.  Altimmune

Dianthus Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Dianthus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Dianthus Therapeutics is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.

Altimmune

Risk-Adjusted Performance

4 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Altimmune are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent essential indicators, Altimmune unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Dianthus Therapeutics and Altimmune

The main advantage of trading using opposite Dianthus Therapeutics and Altimmune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dianthus Therapeutics position performs unexpectedly, Altimmune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Altimmune will offset losses from the drop in Altimmune's long position.

The idea behind Dianthus Therapeutics and Altimmune pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.